Impactful Connections and Intelligence
The global biopharmaceutical industry's one-stop shop of market intelligence and business connections.
Introducing the APAC Bioprocessing Dashboard
A quick-view bioprocessing data & analytics tool with Validated. Quality Data. On A Single Platform.
0
Connections
0
Conventions
0
Clients
0
Countries
0
Children Sent to School
Explore Our Services
B2B EVENTS
Thought leadership, industry knowledge-sharing and quality networking are at the core of IMAPAC's B2B events.
MARKET INTELLIGENCE
Data driven decisions to help organizations grow. In-depth biopharmaceutical industry intelligence brought to you by our team of analysts; fully customizable to your requirements.
LEADGEN 360
Expand your influence, be it through branding & display ads, content creation or thought leadership.
Latest News
November 26, 2021
An innovative, Cell Therapy based CDMO Announces the Expansion of its Facility
Lykan Bioscience, a contract development and manufacturing organisation specialising in cell-based therapeutics, announced the expansion of its facility in Hopkinton, Massachusetts. The increasing need for cell therapy process research and production is driving the expansion and establishment of new innovation lab. As part of the facility expansion plan, seven ISO 7 cGMP suites with autologous […]
Domestic Japanese Infrastructure to Secure Stable Supply of Vaccines
Excerpt Japanese biotech firm Takara Bio Inc. will start producing messenger RNA vaccines on a contract basis possibly from next January, its officials said Thursday November 4th, in a move likely to help cut the country’s reliance on imports for COVID-19 vaccines. Takara Bio is expected to launch in January a production base capable of […]
November 24, 2021
Delivery Agreement for Paediatric Vaccines in Singapore Falls to Pfizer, Says Health Minister
Excerpt Singapore has signed a new supply agreement with Pfizer for its paediatric Covid-19 vaccines for children aged five to 11, said Health Minister Ong Ye Kung on Monday, November 15. The agreement also includes the delivery of these vaccines, and the Ministry of Health (MOH) is in “constant contact” with Pfizer to fulfil these […]
November 24, 2021
WuXi ATU Opens New Facility in Philadelphia for Advanced Therapies Testing
Excerpt WuXi Advanced Therapies, a wholly owned subsidiary of WuXi AppTec, has announced the official launch of its testing facility located in Philadelphia’s Navy Yard. Article Summary The new facility with 140,000 square feet of labs, will improve the firm’s Contract Testing, Development, and Manufacturing Organization business model by expanding the previous testing capacity. This will allow the company to meet […]
November 23, 2021
Hear from Our Clients
Thank you again for producing this really successful and relevant conference. I enjoyed expert conversations with outstanding people and network opportunities were excellent.
Samsung Engineering
South Korea
Excellent event with good knowledge sharing by experienced scientists globally to combat present situation and challenges faced by the vaccine manufacturing industry. Kind hospitality by IMAPAC...Keep it up.
Hester Biosciences Limited
India
Talks were very interesting addressing subjects really important such as the balance of Th1 and Th2 cells as immune response of COVID-19 vaccines. I have achieved a lot watching and rewatching the videos too.
Instituto Butantan
Brazil
It’s my pleasure to be a participant in IMAPAC's 11th World Vaccine summit. This virtual platform supported in exploring more on the current trends on vaccine developments from various manufacturers/ research centers.
BravoVax
China
